Duncan Campbell, Author at New ÐÓ°ÉÔ­´´ Science news and science articles from New ÐÓ°ÉÔ­´´ Fri, 26 Sep 1997 23:00:00 +0000 en-US hourly 1 https://wordpress.org/?v=7.0.1 242057827 Take a deep breath /article/1846513-take-a-deep-breath-2/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Fri, 26 Sep 1997 23:00:00 +0000 http://mg15521015.000 1846513 AIDS patients offered untested and unlicensed ‘remedy’ /article/1815426-aids-patients-offered-untested-and-unlicensed-remedy/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Fri, 16 Jun 1989 23:00:00 +0000 http://mg12216691.600 DOZENS of British patients suffering from AIDS and HIV infection are
being sold a costly, untested and potentially dangerous medicinal product
whose allegedly active ingredients are bacteria cultured from human excrement.
The ‘treatment’, called Delta Te Immune Support Therapy, costs more than
Pounds sterling 1000 a year. Patients who follow the regimen have to take
daily doses of a white powder whose precise composition Yves Delatte, the
salesman of the product, has persistently refused to reveal.

Following enquiries by Thames Television and New Statesman & Society,
Delatte’s activities have recently come under investigation by the Department
of Health. A spokeswoman said: ‘The department is extremely interested in
this issue. There appear to be several breaches of the Medicines Act 1968,
and these are being explored with our legal advisers with a view to an investigation.’

Patients have been encouraged to take the product in place of orthodox
or tested therapies for AIDS, and to commit themselves to buying it and
taking it, possibly for as long as three years. The 1968 Medicines Act prohibits
the sale of medicinal products without a licence, when these are claimed
wholly or mainly to be treatments or preventions for human diseases. If
prosecuted and convicted of importing or selling an unlicensed medicinal
product, Delatte will face fines or imprisonment.

Delatte’s powder is a mixture of a small quantity of cultured human
intestinal bacteria, including Streptococcus faecalis, which is mixed into
starch, milk powder, or acid whey. An analysis for Thames Television of
a sample provided by Delatte showed that the mixture was 90 per cent starch
and between 5 and 10 per cent milk powder, with a small sprinkling of bacteria.

When challenged, Delatte has not disputed that the bacteria are cultured
from human excrement although he has refused to provide details of the ratios
of different strains of bacteria or their weight as a proportion of the
mix. Tubs of the mix weighing 1 kilogram, which cost only a few pounds to
produce, have been sold to patients at a cost of about Pounds sterling 3
per daily dose.

Delatte and other companies who sell for various medicinal purposes
mixtures based on bacteria – usually called ‘probiotics’ – claim that their
powders can beneficially ‘balance’ or restore gut bacterial flora.

However, we know of no clinical research on people that demonstrates
that the patients who take these products in fact suffer from deficiencies
or imbalances of gut flora in the first place. Neither do we know of any
research that determines whether taking additional bacteria has any effect
on gut flora or on health. Bacteria taken orally are often destroyed by
the high acidity of the stomach secretions, so do not reach the large intestine.

According to Brian Gazzard, a consultant at St Stephen’s and the Westminster
hospitals in London, claims about Delta Te are ‘a load of claptrap’. He
‘can’t see any possible benefit at all’ in the product. But he added that
the product could cause harm to people who are ill with AIDS. ‘(The bacteria)
may get access to the circulation and cause harm . . . even with quite moderate
immune suppression, people taking this stuff could develop disease.’

Although Delatte has no medical or scientific qualifications, he has
repeatedly claimed to AIDS patients that Delta Te can ‘restore the immune
system and give it the ability to cure the body’. He admits to selling Delta
Te to 37 AIDS patients to date.

He has ignored warnings about the risks of supplying the product without
licence, and claims that the AIDS patients have all benefited from taking
the powder.

]]>
1815426
AIDS – the Duesberg myth / Review of ‘AIDS: The HIV Myth’ By Jad Adams /article/1815503-aids-the-duesberg-myth-review-of-aids-the-hiv-myth-by-jad-adams/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Fri, 05 May 1989 23:00:00 +0000 http://mg12216635.800 AIDS: The HIV Myth by Jad Adams, Macmillan, pp 244, Pounds sterling
12.95

THE PUBLICATION of this book is an unfortunate event. Jad Adams claims
that AIDS is not caused by infection with HIV. What does cause AIDS, says
Adams, is something he isn’t obliged to work out. It could be ‘lifestyle’
or ‘anything’; anything, that is, except the virus now firmly established
through an urgent programme of medical research as the infectious agent
causing AIDS. The claim that HIV is not the cause of AIDS is neither new
nor Adams’s own. As a nonscientist (who admits that he does not ‘pretend
to objectivity’) Adams relies almost entirely on the arguments against HIV
previously advanced by the Berkeley biochemist, Peter Duesberg.

That Duesberg’s criticisms have repeatedly and effectively been refuted
deters Adams not at all. His reporting is staggeringly inaccurate, scientifically
inept, and continually blighted by the misinterpretation or distortion of
the minimal scientific sources that he has consulted. He has constructed
his book in such remarkable ignorance of so much widely available recent
research and information on AIDS and immunology that it is very hard to
believe that his ignorance is not deliberate.

None of this would matter particularly were it not that a British publisher
of erstwhile high repute, Macmillan (Macmillan Journals are the publishers
of Nature) has put its imprimatur on the book; or were it not that the Royal
Television Society, in its wisdom of matters medical, placed its imprimatur
of the award of the ‘Best International Current Affairs Documentary’ for
1987 on a film Adams made on the subject. Screened by Channel 4 in the series
‘Despatches’ late in 1987, the film was, Adams now admits, ‘not balanced’.

This book follows in exactly the same vein. Macmillan admits that it
did not have Adams’s manuscript checked for accuracy before publication,
and ignored a warning received from an expert working for another Macmillan
pubication, Nursing Times. Adams himself did none of the necessary fact-checking.
In direct consequence, grotesque and dangerous errors abound.

The Adams/Duesberg claims have already done serious harm. AIDS is a
debilitating and still-lethal disease afflicting an increasing number of
otherwise healthy adults. The primary sales target for this book are the
tens of thousands of people in Britain who have personally, directly or
indirectly, to deal with problems of HIV infection and/or AIDS. For them
and their carers, scientific and medical information is a much-sought lifeline,
and a guide on which they are likely to base literally life-and-death decisions.
Such a situation places considerable responsibility on the shoulders of
any serious author or publisher.

Disregard the evidence about the nature of HIV, and you urge HIV and
AIDS patients to distrust entirely the basis on which they now receive medical
care. Already, this effect of Adams’s work has brought one of Britain’s
most renowned AIDS physicians, Charles Farthing, to condemn his efforts
as ‘evil’. So on what scientific basis does Adams (and behind him, Duesberg)
advance the argument that HIV does not cause AIDS? This critical passage
spans only 24 pages, less than 10 per cent of the text. Adams offers two
primary arguments against the HIV/AIDS theory. First, he asserts that the
virus itself cannot be shown to be present in many AIDS patients. Secondly,
he claims that neither in the US nor anywhere else are AIDS patients even
tested for HIV antibodies. ‘There is no check for HIV,’ he writes, because
‘it is so fully accepted as a matter of faith that HIV causes AIDS, no supporting
information is required’. In summary, Adams says, ‘so few AIDS patients
now receive even an antibody test that we cannot be sure what they are carrying.
Virtually anything could be causing their disease.’

These contentions are all absurdly wrong, as the author would have found
out had he once bothered to contact any of the world’s major centres for
AIDS treatment.

Adams’s claim that HIV virus cannot easily be recovered from most people
with AIDS is several years out of date. The claim that most patients are
never tested for HIV antibodies is completely spurious.

‘Paradoxically’, Adams asserts, ‘people with a low level of antibodies
to HIV are considered to be at low risk from AIDS.’ But this is no paradox,
just another error. The 1984 paper Adams cites in support of this claim
states the opposite to be true. People with ‘advanced AIDS’ have ‘significantly
lower’ levels of HIV antibodies than ‘newly-diagnosed’ cases. The paper
on which Adams relies does report finding ‘a high incidence’ of HIV antibodies
among patients at risk of developing AIDS (that is many of them had been
found to have antibodies). The author has become confused and reports this
as meaning ‘a high level’ of concentration of antibodies in their blood.
In publicity material, Macmillan has given high prominence to this error.

The book also asserts that homosexual men are ‘immune-suppressed’ because
of their sexual practices. Adams alludes to reports that in some gay men,
the normal ratio of helper cells to killer cells in the immune system has
been found to be inverted as compared to similar heterosexual men. But the
studies referred to by Adams were all completed before 1985. When HIV tests
became more available, researchers found that the inversion applied only
to gay men who were HIV antibody positive. Gay men, who were antibody negative
were found to have the same immune system parameters as heterosexual men.

The ‘paradox’ which he and Duesberg see as central to their argument
is that even in ‘full-blown’ AIDS the level of HIV in the blood is but a
fraction of what can be found in some other virus-caused diseases. The rate
of destruction of the key T4 ‘helper’ white blood cells by HIV is a million
times too slow to cause any effect, they suggest. Most bizarrely of all,
they say that HIV has too few genes and ‘the wrong structure’ to cause a
fatal disease.

Each of these claims is either false or irrelevant. Low levels of viruses
in the blood are characteristic of retroviruses; and high concentrations
of viruses (viral titres) are never necessary where autoimmune phenomena
are likely to play a large role in the development of a disease. Tests for
the active HIV infection of T cells in the blood are not tests for the level
of infection in other tissues, particularly lymph nodes. There is no ‘paradox’
that very few of a patient’s T4 helper cells can be found expressing HIV
at any one time, because any that do are likely immediately to be destroyed
by the immune system of which they are part. Adams’s claim that HIV has
‘too few genes’ to be pathogenic does not even merit serious attention.

Another repeated assertion is that ‘in all other diseases the virus
titre becomes active and rises in those . . . who are going to get the disease.
Not so with HIV’. Actually, it’s precisely so with HIV. Pioneering work
during 1986 and 1987 identified the re-appearance of HIV antigen in the
blood of someone who was HIV-antibody positive as indicating the early onset
of AIDS. Over the past 18 months, the level of concentration of antigens
has become established as a key laboratory marker of whether anti-AIDS drugs
are effective. Of all this research, as well as the many ‘cohort studies’
(which are now following the long-term development of HIV disease) the author
has kept readers in ignorance.

To explain why the entire scientific world disagrees with him and Duesberg,
Adams perjoratively brands his opponents as members of a homogeneous ‘AIDS
estabishment’, whose scientific prestige and personal prosperity now depend
on maintaining the HIV myth. Extensive quotations from Paul Feyerabend about
the nature of scientific discovery decorate the book, but fail to disguise
the author’s basic ignorance of science and scientific method. There are
periodic allusions to the author’s concern for those afflicted by AIDS,
but these fail to mask his often-stated view that ‘AIDS is a behavioural
disease’. Such a claim is not merely offensive to AIDS sufferers; it flies
in the face of the well-established patterns of transmission via blood and
its products to transfusion recipients, haemophiliacs, and their partners.

Adams claims that everyone who gets AIDS is behaviourally to blame.
Even babies, he has contended, had engaged in ‘a form of behaviour’ by being
in the womb of an HIV-infected mother. Health-care workers who are victims
of needlestick injuries are also to blame.

In his preface, Adams writes: ‘I see no need to apologise for the subjective
style in which this book is written.’ As news reports in New ÐÓ°ÉÔ­´´ have
already indicated (28 April), Adams has made it clear that he sees no need
to apologise for getting his key facts wrong.

But Macmillan, the publisher, is in a different position. It has belligerently
refused to check the accuracy of the book. Appeals to do so have repeatedly
been rejected. It is now many weeks since Macmillan became aware of the
book’s major errors. It is difficult to contemplate any motive, other than
arrogance or greed, which can make a serious publisher so recklessly indifferent
to accuracy in reporting.

Duncan Campbell is associate editor of New Statesman and Society. An
author and broadcaster, he wrote the television series Secret Society.

]]>
1815503
The sharp end of AIDS treatment /article/1815615-the-sharp-end-of-aids-treatment/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Fri, 28 Apr 1989 23:00:00 +0000 http://mg12216622.300 INVESTIGATIONS have exposed a ‘treatment’ for AIDS and cancer, for which
patients have paid thousands of pounds, as an unethical experiment. James
Sharp, a former consultant haematologist in the National Health Service,
offered the therapy at the privately-run London Bridge Hospital in London.
Patients dying from AIDS, cancer and leukaemia paid his clinic more than
Pounds sterling 100 000.

The clinic which Sharp established sacked him both as a manager and
as a doctor earlier this year. A group of senior doctors are reporting him
to the General Medical Council for serious professional misconduct.

I wrote an article detailing Sharp’s activities in the New Statesman
and Society on 7 April, following research carried out in conjunction with
BBC television’s Watchdog programme four days earlier. Sharp’s activities
were reported in New ÐÓ°ÉÔ­´´ last year (AIDS Monitor, 26 May 1988).

Sharp claimed that his research on two patients with AIDS-related complex
indicated that his technique, called adoptive immunotherapy, could ‘stabilise’
AIDS.

Sharp said that, following his therapy, he had observed ‘significant
long-lasting clinical improvements’, including weight gain and disappearance
of a fungal infection, thrush, from the mouth of one of the patients. Sharp
extracted white blood cells from the patient and stimulated the cells in
the laboratory with alpha-interferon, a natural chemical normally produced
by cells of the immune system. Sharp then reinfused the cells into the patient.

Sharp’s colleague, Abdul Jabar Sultan, devised the process. His only
professional qualification was to practise veterinary medicine in Iraq.
Sultan had joined Sharp after being ordered to leave King’s College Hospital,
London, following his failure to complete a PhD. London Bridge Hospital
has closed the adoptive immunotherapy unit that Sultan set up there. Sultan
no longer works for the hospital.

Two senior doctors warned Sultan and Sharp at least twice that the techniques
of adoptive immunotherapy would be dangerous and unethical to use in patients
with AIDS because, if anything, the ‘treatment’ would be likely to accelerate
the disease. But Sharp and Sultan went on to treat three AIDS patients and
at least 30 other patients who were terminally ill with either cancer or
leukaemia. All the patients with AIDS died within five months of starting
the treatment; most of the people with cancer and leukaemia have also died.

One of the patients with AIDS-related complex, reported in New ÐÓ°ÉÔ­´´
as having experienced an improvement in health following the treatment,
has now come forward. He and his NHS doctor refute Sharp’s claim that his
health had improved in the manner alleged.

I exposed Sharp by consulting the doctor in the company of a healthy
man who did not harbour HIV, the virus that causes AIDS, and who pretended
to have serious symptoms of AIDS. Sharp did not notice the pretence because
he made no attempt to examine the ‘patient’ medically or check his previous
medical history before prescribing him (within minutes) a course of immunotherapy
costing Pounds sterling 10 000. Sharp suggested that this therapy should
begin the next morning.

]]>
1815615